Ester Martı́n-Aparicio

Neuronal Induction of the Immunoproteasome in Huntington's Disease

Miguel Dı́az-Hernández, Félix Hernández, Ester Martı́n-Aparicio et al. · Journal of Neuroscience · 2003 · 250 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Proteasomal-Dependent Aggregate Reversal and Absence of Cell Death in a Conditional Mouse Model of Huntington's Disease

Ester Martı́n-Aparicio, Ai Yamamoto, Félix Hernández et al. · Journal of Neuroscience · 2001 · 169 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Glycogen Synthase Kinase-3 (GSK-3) Inhibitory Activity and Structure–Activity Relationship (SAR) Studies of the Manzamine Alkaloids. Potential for Alzheimer’s Disease

Mark T. Hamann, D. A. Alonso, Ester Martı́n-Aparicio et al. · Journal of Natural Products · 2007 · 145 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice

Angelo O. Rosa, Manuella P. Kaster, Ricardo W. Binfaré et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2008 · 127 citations

Medicine, Medicinal Chemistry, Pharmacology +13

Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington’s disease

Isabel Lastres‐Becker, Fernando Berrendero, José J. Lucas et al. · Brain Research · 2002 · 103 citations

Life Sciences, Molecular Biology, Neuroscience +14